30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United Kingdom Biotechnology & Medical Research

Amarin Corporation PLC (AMRN)

Track

The most recent insider trading activity occurred on August 2, 2024, with a significant buy transaction by the President and CEO. Prior to this, there were several buy transactions by the President and CEO in January 2024 and August 2023. A proposed sale by an officer was noted in December 2023.
Stock chart
Ticker: AMRN Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Berg Aaron
President and CEO
1 purchase — total 102,400 USD
Buy 2 Aug 2024
Value US$2,872,748.44 | Price 346.64 | Shares 58,973
Buy 22 Jan 2024
Value US$4,636,406.75 | Price 328.92 | Shares 73,694
Planned sale 12 Dec 2023
Value US$26,963.49 | Price 0.79 | Shares 34,131
Proposed sale 12 Dec 2023
Value US$28,564.23 | Price 0.84 | Shares 34,131
Buy 16 Aug 2023
Value US$71,255.32 | Price 1.06 | Shares 67,222
Buy 16 Aug 2023
Value US$27,266.48 | Price 1.06 | Shares 25,845
Buy 16 Aug 2023
Value US$13,335.00 | Price 1.05 | Shares 12,700
Buy 16 Aug 2023
Value US$31,867.68 | Price 1.04 | Shares 30,642
Buy 16 Aug 2023
Value US$20,035.53 | Price 1.04 | Shares 19,358
Buy 16 Aug 2023
Value US$147,573.25 | Price 1.03 | Shares 143,275
Buy 16 Aug 2023
Value US$981.95 | Price 1.03 | Shares 958
Buy 13 Jun 2022
Value US$92,730.00 | Price 1.69 | Shares 55,000
Buy 15 Dec 2021
Value US$6,310.00 | Price 3.16 | Shares 2,000
Buy 14 Dec 2021
Value US$32,689.00 | Price 3.27 | Shares 10,000
Buy 4 Jun 2021
Value US$45,350.00 | Price 4.54 | Shares 10,000
Buy 3 Jun 2021
Value US$23,115.00 | Price 4.62 | Shares 5,000
Planned sale 1 Feb 2021
Value US$203,670.36 | Price 8.03 | Shares 25,370
Planned sale 1 Feb 2021
Value US$1,550,463.19 | Price 8.06 | Shares 192,358
Planned sale 27 Jan 2021
Value US$1,149,258.20 | Price 8.01 | Shares 143,392
Planned sale 27 Jan 2021
Value US$2,228,873.14 | Price 8.01 | Shares 278,237
Buy 30 Nov 2020
Value US$121,517.50 | Price 4.86 | Shares 25,000
Sale 11 Nov 2020
Value US$1,681,183.08 | Price 4.07 | Shares 413,565
Sale 10 Nov 2020
Value US$635,974.56 | Price 4.13 | Shares 153,840
Planned sale 4 Mar 2020
Value US$3,198,700.00 | Price 15.99 | Shares 200,000
Planned sale 3 Jan 2020
Value US$6,282,870.00 | Price 20.94 | Shares 300,000
Planned sale 16 Dec 2019
Value US$2,583,380.00 | Price 25.83 | Shares 100,000
Planned sale 16 Dec 2019
Value US$1,101,364.11 | Price 25.46 | Shares 43,253
Planned sale 16 Dec 2019
Value US$2,566.00 | Price 25.66 | Shares 100
Planned sale 16 Dec 2019
Value US$24,836.00 | Price 24.84 | Shares 1,000
Planned sale 16 Dec 2019
Value US$178,586.25 | Price 23.81 | Shares 7,500
Planned sale 16 Dec 2019
Value US$378,023.28 | Price 23.05 | Shares 16,400
Planned sale 19 Nov 2019
Value US$6,217,371.13 | Price 22.65 | Shares 274,454
Planned sale 12 Nov 2019
Value US$746,759.46 | Price 19.35 | Shares 38,600
Planned sale 11 Nov 2019
Value US$746,295.69 | Price 17.88 | Shares 41,741
Planned sale 11 Nov 2019
Value US$7,397,156.10 | Price 17.05 | Shares 433,805
Planned sale 5 Nov 2019
Value US$115,230.08 | Price 18.00 | Shares 6,400
Planned sale 3 Sep 2019
Value US$1,365,722.38 | Price 15.01 | Shares 91,016
Planned sale 11 Jul 2019
Value US$1,158,354.28 | Price 22.28 | Shares 51,991
Planned sale 5 Jul 2019
Value US$2,381,580.00 | Price 23.82 | Shares 100,000
Planned sale 3 Jul 2019
Value US$662,237.55 | Price 22.64 | Shares 29,250
Planned sale 2 Jul 2019
Value US$419,060.88 | Price 21.42 | Shares 19,564
Planned sale 2 Jul 2019
Value US$1,023,080.00 | Price 20.46 | Shares 50,000
Planned sale 1 Jul 2019
Value US$1,057,905.79 | Price 19.52 | Shares 54,186
Planned sale 1 Jul 2019
Value US$983,270.00 | Price 19.67 | Shares 50,000
Planned sale 24 Jun 2019
Value US$2,104,521.44 | Price 18.59 | Shares 113,195
Planned sale 18 Jun 2019
Value US$1,902,090.00 | Price 19.02 | Shares 100,000
Planned sale 31 May 2019
Value US$488,058.04 | Price 17.92 | Shares 27,229
Planned sale 29 May 2019
Value US$623,534.09 | Price 18.45 | Shares 33,799
Planned sale 17 May 2019
Value US$237,138.59 | Price 18.00 | Shares 13,174
Planned sale 30 Apr 2019
Value US$508,838.84 | Price 18.69 | Shares 27,230
Planned sale 30 Apr 2019
Value US$178,106.62 | Price 18.67 | Shares 9,541
Planned sale 1 Apr 2019
Value US$2,078.00 | Price 20.78 | Shares 100
Planned sale 1 Apr 2019
Value US$189,313.99 | Price 20.05 | Shares 9,442
Planned sale 1 Apr 2019
Value US$1,062,993.43 | Price 20.03 | Shares 53,060
Planned sale 4 Mar 2019
Value US$796,830.40 | Price 21.71 | Shares 36,700
Planned sale 4 Mar 2019
Value US$2,088,074.39 | Price 21.16 | Shares 98,677
Planned sale 4 Mar 2019
Value US$1,533,893.86 | Price 21.70 | Shares 70,673
Planned sale 4 Mar 2019
Value US$3,793,339.90 | Price 21.15 | Shares 179,327
Planned sale 1 Mar 2019
Value US$498,581.54 | Price 22.59 | Shares 22,075
Planned sale 1 Mar 2019
Value US$1,561,721.38 | Price 22.06 | Shares 70,801
Planned sale 1 Mar 2019
Value US$148,795.43 | Price 20.89 | Shares 7,124
Planned sale 1 Mar 2019
Value US$160,717.10 | Price 22.64 | Shares 7,099
Planned sale 1 Mar 2019
Value US$782,196.69 | Price 22.10 | Shares 35,398
Planned sale 1 Mar 2019
Value US$73,361.23 | Price 20.94 | Shares 3,503
Planned sale 28 Feb 2019
Value US$564,171.86 | Price 20.72 | Shares 27,231
Planned sale 28 Feb 2019
Value US$197,249.04 | Price 20.67 | Shares 9,543
Planned sale 22 Feb 2019
Value US$3,274,038.45 | Price 20.02 | Shares 163,500
Planned sale 22 Feb 2019
Value US$3,594,437.50 | Price 19.90 | Shares 180,625
Planned sale 22 Feb 2019
Value US$948,500.00 | Price 18.97 | Shares 50,000
Planned sale 22 Feb 2019
Value US$4,071,422.91 | Price 20.02 | Shares 203,382
Planned sale 15 Feb 2019
Value US$439,525.00 | Price 17.58 | Shares 25,000
Planned sale 1 Feb 2019
Value US$477,497.94 | Price 17.06 | Shares 27,989
Planned sale 31 Jan 2019
Value US$745,468.19 | Price 17.49 | Shares 42,624
Planned sale 31 Jan 2019
Value US$166,874.95 | Price 17.49 | Shares 9,541
Planned sale 24 Jan 2019
Value US$10,754,717.17 | Price 17.66 | Shares 609,115
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-08-05 2024-08-02 B Purchase
0.9
Berg Aaron

President and CEO

Officer
58,973 -29.4%
346.64
US$2,872,748 		58,973 -29.4% 346.64 US$2,872,748
2024-01-24 2024-01-22 B Purchase
1.3
Holt Patrick

President and CEO

Executive Director
73,694 -2.9%
328.92
US$4,636,407 		73,694 -2.9% 328.92 US$4,636,407
2023-12-14 2023-12-12 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
24,287 -35.0%
90.24
US$3,867,757 		24,287 -35.0% 90.24 US$3,867,757
2023-12-12 2023-12-12 PrS Proposed sale
STEVEN B. KETCHUM

Officer

Officer
34,131
0.84
US$28,564 		34,131 0.84 US$28,564
2023-08-16 2023-08-16 B Purchase
1.3
Holt Patrick

President and CEO

Executive Director
67,222 +28.9%
1.06
US$71,255 		67,222 +28.9% 1.06 US$71,255
2023-08-16 2023-08-16 B Purchase
1.3
Holt Patrick

President and CEO

Executive Director
25,845 +12.4%
1.06
US$27,266 		25,845 +12.4% 1.06 US$27,266
2023-08-16 2023-08-16 B Purchase
1.3
Holt Patrick

President and CEO

Executive Director
12,700 +6.5%
1.05
US$13,335 		12,700 +6.5% 1.05 US$13,335
2023-08-16 2023-08-16 B Purchase
1.3
Holt Patrick

President and CEO

Executive Director
30,642 +18.7%
1.04
US$31,868 		30,642 +18.7% 1.04 US$31,868
2023-08-16 2023-08-16 B Purchase
1.3
Holt Patrick

President and CEO

Executive Director
19,358 +13.4%
1.04
US$20,036 		19,358 +13.4% 1.04 US$20,036
2023-08-16 2023-08-16 B Purchase
1.3
Holt Patrick

President and CEO

Executive Director
143,275 +14955.6%
1.03
US$147,573 		143,275 +14955.6% 1.03 US$147,573
2023-08-16 2023-08-16 B Purchase
1.3
Holt Patrick

President and CEO

Executive Director
958 +inf%
1.03
US$982 		958 +inf% 1.03 US$982
2022-06-15 2022-06-13 B Purchase
1.4
WOLD OLSEN PER
Non-Executive Director
55,000 +58.5%
1.69
US$92,730 		55,000 +58.5% 1.69 US$92,730
2021-12-16 2021-12-15 B Purchase
4.3
Zakrzewski Joseph S
Non-Executive Director
2,000 +1.0%
3.16
US$6,310 		2,000 +1.0% 3.16 US$6,310
2021-12-16 2021-12-14 B Purchase
4.3
Zakrzewski Joseph S
Non-Executive Director
10,000 +5.4%
3.27
US$32,689 		10,000 +5.4% 3.27 US$32,689
2021-06-07 2021-06-04 B Purchase
2.8
STACK DAVID M
Non-Executive Director
10,000 +33.3%
4.54
US$45,350 		10,000 +33.3% 4.54 US$45,350
2021-06-07 2021-06-03 B Purchase
2.8
STACK DAVID M
Non-Executive Director
5,000 +20.0%
4.62
US$23,115 		5,000 +20.0% 4.62 US$23,115
2021-02-03 2021-02-01 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
25,370 -6.2%
8.03
US$203,670 		25,370 -6.2% 8.03 US$203,670
2021-02-03 2021-02-01 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
192,358 -32.0%
8.06
US$1,550,463 		192,358 -32.0% 8.06 US$1,550,463
2021-01-29 2021-01-27 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
143,392 -27.0%
8.01
US$1,149,258 		143,392 -27.0% 8.01 US$1,149,258
2021-01-29 2021-01-27 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
278,237 -34.4%
8.01
US$2,228,873 		278,237 -34.4% 8.01 US$2,228,873
2020-12-02 2020-11-30 B Purchase
2.8
STACK DAVID M
Non-Executive Director
25,000 +inf%
4.86
US$121,518 		25,000 +inf% 4.86 US$121,518
2020-11-12 2020-11-11 S Sale
1.3
THERO JOHN F

President and CEO

Executive Director
413,565 -13.1%
4.07
US$1,681,183 		413,565 -13.1% 4.07 US$1,681,183
2020-11-12 2020-11-10 S Sale
1.3
THERO JOHN F

President and CEO

Executive Director
153,840 -4.7%
4.13
US$635,975 		153,840 -4.7% 4.13 US$635,975
2020-03-06 2020-03-04 PlS Planned sale
1.3
THERO JOHN F

President and CEO
200,000 -7.5%
15.99
US$3,198,700 		200,000 -7.5% 15.99 US$3,198,700
2020-01-03 2020-01-03 PlS Planned sale
4.3
Zakrzewski Joseph S
300,000 -78.0%
20.94
US$6,282,870 		300,000 -78.0% 20.94 US$6,282,870
2019-12-18 2019-12-16 PlS Planned sale Zakrzewski Joseph S Non-Executive Director
100,000 -54.2%
25.83
US$2,583,380 		100,000 -54.2% 25.83 US$2,583,380
2019-12-18 2019-12-16 PlS Planned sale Berg Aaron

CHIEF COMMERCIAL OFFICER

Officer
43,253 -24.4%
25.46
US$1,101,364 		43,253 -24.4% 25.46 US$1,101,364
2019-12-18 2019-12-16 PlS Planned sale Kalb Michael Wayne

SVP and CFO

Officer
100 -0.5%
25.66
US$2,566 		100 -0.5% 25.66 US$2,566
2019-12-18 2019-12-16 PlS Planned sale Kalb Michael Wayne

SVP and CFO

Officer
1,000 -4.4%
24.84
US$24,836 		1,000 -4.4% 24.84 US$24,836
2019-12-18 2019-12-16 PlS Planned sale Kalb Michael Wayne

SVP and CFO

Officer
7,500 -24.9%
23.81
US$178,586 		7,500 -24.9% 23.81 US$178,586
2019-12-18 2019-12-16 PlS Planned sale Kalb Michael Wayne

SVP and CFO

Officer
16,400 -35.2%
23.05
US$378,023 		16,400 -35.2% 23.05 US$378,023
2019-11-21 2019-11-19 PlS Planned sale THERO JOHN F

President and CEO

Executive Director
274,454 -10.5%
22.65
US$6,217,371 		274,454 -10.5% 22.65 US$6,217,371
2019-11-13 2019-11-12 PlS Planned sale Ekman Lars Non-Executive Director
38,600 -100.0%
19.35
US$746,759 		38,600 -100.0% 19.35 US$746,759
2019-11-13 2019-11-11 PlS Planned sale THERO JOHN F

President and CEO

Executive Director
41,741 -1.6%
17.88
US$746,296 		41,741 -1.6% 17.88 US$746,296
2019-11-13 2019-11-11 PlS Planned sale THERO JOHN F

President and CEO

Executive Director
433,805 -14.0%
17.05
US$7,397,156 		433,805 -14.0% 17.05 US$7,397,156
2019-11-07 2019-11-05 PlS Planned sale
Ekman Lars
6,400 -100.0%
18.00
US$115,230 		6,400 -100.0% 18.00 US$115,230
2019-09-05 2019-09-03 PlS Planned sale
Ekman Lars
91,016 -100.0%
15.01
US$1,365,722 		91,016 -100.0% 15.01 US$1,365,722
2019-07-12 2019-07-11 PlS Planned sale
2.8
STACK DAVID M
51,991 -100.0%
22.28
US$1,158,354 		51,991 -100.0% 22.28 US$1,158,354
2019-07-05 2019-07-05 PlS Planned sale
4.3
Zakrzewski Joseph S
100,000 -54.2%
23.82
US$2,381,580 		100,000 -54.2% 23.82 US$2,381,580
2019-07-03 2019-07-03 PlS Planned sale
0.9
Berg Aaron

CHIEF COMMERCIAL OFFICER
29,250 -44.6%
22.64
US$662,238 		29,250 -44.6% 22.64 US$662,238
2019-07-03 2019-07-02 PlS Planned sale
0.9
Berg Aaron

CHIEF COMMERCIAL OFFICER
19,564 -35.0%
21.42
US$419,061 		19,564 -35.0% 21.42 US$419,061
2019-07-03 2019-07-02 PlS Planned sale
0.9
Berg Aaron

CHIEF COMMERCIAL OFFICER
50,000 -47.2%
20.46
US$1,023,080 		50,000 -47.2% 20.46 US$1,023,080
2019-07-03 2019-07-01 PlS Planned sale
Kennedy Joseph T

General Counsel
54,186 -63.4%
19.52
US$1,057,906 		54,186 -63.4% 19.52 US$1,057,906
2019-07-03 2019-07-01 PlS Planned sale
Kalb Michael Wayne

SVP and CFO
50,000 -70.6%
19.67
US$983,270 		50,000 -70.6% 19.67 US$983,270
2019-06-26 2019-06-24 PlS Planned sale
0.9
Berg Aaron

CHIEF COMMERCIAL OFFICER
113,195 -75.7%
18.59
US$2,104,521 		113,195 -75.7% 18.59 US$2,104,521
2019-06-20 2019-06-18 PlS Planned sale
4.3
Zakrzewski Joseph S
100,000 -54.2%
19.02
US$1,902,090 		100,000 -54.2% 19.02 US$1,902,090
2019-05-31 2019-05-31 PlS Planned sale
Kennedy Joseph T

General Counsel
27,229 -46.6%
17.92
US$488,058 		27,229 -46.6% 17.92 US$488,058
2019-05-31 2019-05-29 PlS Planned sale
2.8
STACK DAVID M
Non-Executive Director
33,799 -100.0%
18.45
US$623,534 		33,799 -100.0% 18.45 US$623,534
2019-05-21 2019-05-17 PlS Planned sale
2.8
STACK DAVID M
Non-Executive Director
13,174 -100.0%
18.00
US$237,139 		13,174 -100.0% 18.00 US$237,139
2019-05-02 2019-04-30 PlS Planned sale
Kennedy Joseph T

General Counsel
27,230 -46.6%
18.69
US$508,839 		27,230 -46.6% 18.69 US$508,839
2019-05-02 2019-04-30 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
9,541 -2.6%
18.67
US$178,107 		9,541 -2.6% 18.67 US$178,107
2019-04-01 2019-04-01 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer
100 -0.0%
20.78
US$2,078 		100 -0.0% 20.78 US$2,078
2019-04-01 2019-04-01 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer
9,442 -2.6%
20.05
US$189,314 		9,442 -2.6% 20.05 US$189,314
2019-04-01 2019-04-01 PlS Planned sale
Kennedy Joseph T

General Counsel
53,060 -62.1%
20.03
US$1,062,993 		53,060 -62.1% 20.03 US$1,062,993
2019-03-06 2019-03-04 PlS Planned sale
Ekman Lars
36,700 -100.0%
21.71
US$796,830 		36,700 -100.0% 21.71 US$796,830
2019-03-06 2019-03-04 PlS Planned sale
Ekman Lars
98,677 -72.9%
21.16
US$2,088,074 		98,677 -72.9% 21.16 US$2,088,074
2019-03-06 2019-03-04 PlS Planned sale
1.3
THERO JOHN F

President and CEO

Executive Director
70,673 -3.3%
21.70
US$1,533,894 		70,673 -3.3% 21.70 US$1,533,894
2019-03-06 2019-03-04 PlS Planned sale
1.3
THERO JOHN F

President and CEO

Executive Director
179,327 -7.7%
21.15
US$3,793,340 		179,327 -7.7% 21.15 US$3,793,340
2019-03-01 2019-03-01 PlS Planned sale
Kalb Michael Wayne

SVP and CFO

Officer
22,075 -51.8%
22.59
US$498,582 		22,075 -51.8% 22.59 US$498,582
2019-03-01 2019-03-01 PlS Planned sale
Kalb Michael Wayne

SVP and CFO

Officer
70,801 -62.4%
22.06
US$1,561,721 		70,801 -62.4% 22.06 US$1,561,721
2019-03-01 2019-03-01 PlS Planned sale
Kalb Michael Wayne

SVP and CFO

Officer
7,124 -5.9%
20.89
US$148,795 		7,124 -5.9% 20.89 US$148,795
2019-03-01 2019-03-01 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
7,099 -2.0%
22.64
US$160,717 		7,099 -2.0% 22.64 US$160,717
2019-03-01 2019-03-01 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
35,398 -8.9%
22.10
US$782,197 		35,398 -8.9% 22.10 US$782,197
2019-03-01 2019-03-01 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
3,503 -0.9%
20.94
US$73,361 		3,503 -0.9% 20.94 US$73,361
2019-03-01 2019-02-28 PlS Planned sale
Kennedy Joseph T

General Counsel

Officer
27,231 -46.6%
20.72
US$564,172 		27,231 -46.6% 20.72 US$564,172
2019-03-01 2019-02-28 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
9,543 -2.6%
20.67
US$197,249 		9,543 -2.6% 20.67 US$197,249
2019-02-22 2019-02-22 PlS Planned sale
Peterson Kristine
Non-Executive Director
163,500 -100.0%
20.02
US$3,274,038 		163,500 -100.0% 20.02 US$3,274,038
2019-02-22 2019-02-22 PlS Planned sale
4.3
Zakrzewski Joseph S
Non-Executive Director
180,625 -68.1%
19.90
US$3,594,438 		180,625 -68.1% 19.90 US$3,594,438
2019-02-22 2019-02-22 PlS Planned sale
Kalb Michael Wayne

SVP and CFO

Officer
50,000 -70.9%
18.97
US$948,500 		50,000 -70.9% 18.97 US$948,500
2019-02-22 2019-02-22 PlS Planned sale
3.4
VAN HEEK G JAN
Non-Executive Director
203,382 -93.5%
20.02
US$4,071,423 		203,382 -93.5% 20.02 US$4,071,423
2019-02-15 2019-02-15 PlS Planned sale
Kalb Michael Wayne

SVP and CFO

Officer
25,000 -54.9%
17.58
US$439,525 		25,000 -54.9% 17.58 US$439,525
2019-02-01 2019-02-01 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
27,989 -7.3%
17.06
US$477,498 		27,989 -7.3% 17.06 US$477,498
2019-02-01 2019-01-31 PlS Planned sale
Kennedy Joseph T

General Counsel

Officer
42,624 -57.7%
17.49
US$745,468 		42,624 -57.7% 17.49 US$745,468
2019-02-01 2019-01-31 PlS Planned sale
Ketchum Steven B

Chief Scientific Officer

Officer
9,541 -2.7%
17.49
US$166,875 		9,541 -2.7% 17.49 US$166,875
2019-01-24 2019-01-24 PlS Planned sale
Kennedy Joseph T

General Counsel

Officer
609,115 -100.0%
17.66
US$10,754,717 		609,115 -100.0% 17.66 US$10,754,717
Explore more

More insider trading research around Amarin Corporation PLC

More insider trades in United Kingdom
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe